Liver De Novo Lipogenesis
Cross-source consensus on Liver De Novo Lipogenesis from 1 sources and 6 claims.
1 sources · 6 claims
How it works
Highlighted claims
- The liver packages triglycerides produced through de novo lipogenesis into VLDL particles. — Small LDL and Coronary Disease Risk
- De novo lipogenesis is the liver process that converts dietary sugars and carbohydrates into triglycerides. — Small LDL and Coronary Disease Risk
- De novo lipogenesis is the central pathway connecting carbohydrate intake to small dense LDL formation and coronary disease risk. — Small LDL and Coronary Disease Risk
- Portal vein endotoxemia from SIBO stimulates the liver to increase de novo lipogenesis. — Small LDL and Coronary Disease Risk
- Diet, gut-derived endotoxin, liver fat production, visceral fat, insulin resistance, and inflammation create a self-reinforcing vicious cycle. — Small LDL and Coronary Disease Risk
- Dietary sugars and starches, rather than saturated fat alone, are placed at the start of the coronary disease risk-producing chain. — Small LDL and Coronary Disease Risk